Your browser doesn't support javascript.
loading
Artificial intelligence-driven identification of morin analogues acting as CaV1.2 channel blockers: Synthesis and biological evaluation.
Carullo, Gabriele; Falbo, Federica; Ahmed, Amer; Trezza, Alfonso; Gianibbi, Beatrice; Nicolotti, Orazio; Campiani, Giuseppe; Aiello, Francesca; Saponara, Simona; Fusi, Fabio.
Afiliação
  • Carullo G; Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Falbo F; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ed. Polifunzionale, 87036, Rende (CS), Italy.
  • Ahmed A; Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Trezza A; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Gianibbi B; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Nicolotti O; Department of Pharmacy- Drug Sciences, University of Bari "Aldo Moro", Via Orabona 4, 70125 Bari, Italy.
  • Campiani G; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Aiello F; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ed. Polifunzionale, 87036, Rende (CS), Italy. Electronic address: francesca.aiello@unical.it.
  • Saponara S; Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Fusi F; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
Bioorg Chem ; 131: 106326, 2023 02.
Article em En | MEDLINE | ID: mdl-36563413
ABSTRACT
Morin is a vasorelaxant flavonoid, whose activity is ascribable to CaV1.2 channel blockade that, however, is weak as compared to that of clinically used therapeutic agents. A conventional strategy to circumvent this drawback is to synthesize new derivatives differently decorated and, in this context, morin-derivatives able to interact with CaV1.2 channels were found by employing the potential of PLATO in target fishing and reverse screening. Three different derivatives (5a-c) were selected as promising tools, synthesized, and investigated in in vitro functional studies using rat aorta rings and rat tail artery myocytes. 5a-c were found more effective vasorelaxant agents than the naturally occurring parent compound and antagonized both electro- and pharmaco-mechanical coupling in an endothelium-independent manner. 5a, the series' most potent, reduced also Ca2+ mobilization from intracellular store sites. Furthermore, 5a≈5c > 5b inhibited Ba2+ current through CaV1.2 channels. However, compound 5a caused also a concentration-dependent inhibition of KCa1.1 channel currents.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatação / Vasodilatadores / Flavonoides / Inteligência Artificial / Bloqueadores dos Canais de Cálcio / Canais de Cálcio Tipo L Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatação / Vasodilatadores / Flavonoides / Inteligência Artificial / Bloqueadores dos Canais de Cálcio / Canais de Cálcio Tipo L Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article